To characterize not only the ultimate phenotype of anti-tumor effectors after B/I activation, but also the origin of the adoptively transferred cells that mediate the anti-tumor activity, we separated tDLN into CD62L+ and CD62L- fractions, both before and after B/I stimulation and expansion. Here, SELL is linked to neoplasm.